Media & Research

SYMBYX recently closed our A-Round Funding and raised more than $3 million (AUD) from a small group of highly credentialed investors, including Australian-based venture capital and global medical company founders. We thank them for sharing our vision of widespread use of Photobiomodulation therapy in the treatment of diverse conditions, including Parkinson’s, Fibromyalgia and other gut mediated indications. 

"PBM was shown to be a safe and potentially effective treatment for a range of clinical signs and symptoms of PD. Improvements were maintained for as long as treatment continued, for up to one year in a neurodegenerative disease where decline is typically expected". BMC Neurology, July 2021.

A (fibromyalgia) flare-up starts with instant exhaustion and a brain fog so dense I might struggle to speak, writes Nikki Marshall of The Guardian newspaper, 30 June 2021. "Then the pain begins. It’s a rusty feeling in my hands and feet that moves up and seeps into my wrists and ankles, elbows and knees, shoulders and hips..."

There is increasing interest in our microbiomes and the connection between gut and brain health. This study is another intriguing piece of the puzzle highlighting the importance of lifestyle factors and diet. Importantly, it also points to new much-needed treatment opportunities for the diseases that cause dementia – now the leading cause of death in the UK and elsewhere. 

Chronic gut inflammation can trigger the clumping of alpha-synuclein in the walls of the colon, a new study reports. Researchers found chronic inflammation in the gut during early life can exacerbate the clumping of alpha-synuclein in the brains of older mice. The findings add to a growing body of evidence which links gut health to Parkinson’s disease.

Call it a sign of the times: Microbiomes—the network of bacteria, fungi, viruses and other microorganisms (or microbiota) that our bodies play host to—have been getting more attention of late. Though they’re known for aiding digestion, their role in healthy immune function may be what’s currently boosting their reputation. “With the emergence of Covid, we’re all becoming aware of just how important it [the microbiome] is,

Mosman businessman Peter Carre developed a passion for medical technology when his daughter Jamie was badly injured playing representative basketball in 2011.

The teenager fell during a Championship game for Norths, rupturing a ligament in her right hand that forced the power forward out of the Sydney competition.

“It was a terrible injury for a young girl showing great promise in the world of Basketball,” Peter says, “I was heartbroken for my daughter and wanted to do whatever I could to help get Jamie back on the court.”

Sidelined for the rest of the season and frustrated by long bouts of rehabilitation, the young athlete asked her American father to investigate alternative treatments.

“So, I called an old friend who just happened to be Team Doctor for the Orlando Magic,” Peter laughs, “and the rest is history.”

Provisional results, from the first half dozen Adelaide participants to have their gut microbiome analysed before treatment and 12 weeks after treatment began, have been promising. “The six patients that have been put through a similar protocol as the mice showed an increase by up to 20 per cent in the favourable microbiome which is associated with obesity reduction and short chain fatty acid production, and the bacteria associated with rheumatoid arthritis, Crohn’s disease and insulin resistance were all decreased,” Cardiac Health Institute medical director and Professor of Cardiology at Macquarie University, Hosen Kiat, who oversaw the trial, told me.

 

Peripheral neuropathy commonly just called 'Neuropathy' is a common side effect of chemotherapy. Doctors believe it happens because chemotherapy damages healthy cells, including peripheral nerves that affect feeling and movement in the hands and feet. The peripheral nerves are the communication network that sends signals from the central nervous system - the brain and spinal cord - to all other parts of the body.

Scientific research using animal models showed that there were strong reductions in clinical signs of Parkinson’s and that the vulnerable cells were protected using laser therapy, says Daniel Johnstone, PhD, and Neuroscientist at University of Sydney.

As discussed in a peer reviewed article published last year, The Dark Art of Light Measurement (accurate radiometry for low-level light therapy) ph...

CEO's Message - Dr Wayne Markman Please subscribe via our website for further updates, connect with us on social media and/or be in touch with us ...